Article Text

PDF

Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
  1. P A Crossey,
  2. C Eng,
  3. M Ginalska-Malinowska,
  4. T W Lennard,
  5. D C Wheeler,
  6. B A Ponder,
  7. E R Maher
  1. Human Molecular Genetics Group, University of Cambridge, Department of Pathology, Addenbrooke's Hospital, UK.

    Abstract

    Inherited predisposition to phaeochromocytoma is seen in multiple endocrine neoplasia type 2 syndromes, von Hippel-Lindau (VHL) disease, and neuro-fibromatosis type 1. In addition familial phaeochromocytoma alone has been reported. To investigate the genetic basis for familial phaeochromocytoma alone, we screened three affected kindreds for mutations in the RET proto-oncogene and the VHL tumour suppressor gene. We did not detect MEN 2 associated RET mutations in any family, but missense VHL gene mutations (V155L and R238W) were identified in two kindreds with no clinical evidence of VHL disease. Patients with familial, multiple, or early onset phaeochromocytoma should be investigated for germline VHL and RET gene mutations as the molecular diagnosis of multisystem familial cancer syndromes enables appropriate counselling and screening to be provided.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.